Stock Rich List
#12736 on the rich list of 14,644 insiders

John W. Smither

Chief Financial Officer at Arcutis Biotherapeutics; Chief Financial Officer at MBX Biosciences; Director at Genelux.

$6.0M
in disclosed stock, −$66K (−1.08%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
12736th of 14,644
Companies held
4
Largest holding
ARQT, 68.9% of total
Latest SEC filing
Sep 4, 2026

What the $6.0M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Arcutis Biotherapeutics ARQT
Common Stock
Through Trust141,392$27.17$3.8M63.8%Form 4, Feb 13, 2024
MBX Biosciences MBX
Common Stock
Directly28,000$53.41$1.5M24.8%Form 4, Aug 3, 2026
Arcutis Biotherapeutics ARQT
Common Stock
Directly11,365$27.17$309K5.1%Form 4, Feb 13, 2024
Genelux GNLX
Common Stock
Directly91,403$2.28$208K3.5%Form 4, Jul 1, 2026
NewAmsterdam Pharma Company NAMS
Ordinary Shares
Directly8,760$19.51$171K2.8%Form 4, Sep 4, 2026

Share counts are the amounts John W. Smither reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Sep 4, 2026SoldNAMS1,600$25.32$41KView
Jul 1, 2026SoldGNLX12,000$2.91$35KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
12733Nicholas C. Gangestad
Sr. VP and CFO, Rockwell Automation. Charlotte, NC
$6.0M−$168K (−2.71%)
12734Paul Seavey
EVP & Chief Financial Officer, Equity LifeStyle Properties. Chicago, IL
$6.0M−$98K (−1.61%)
12735Nitin Sood
Chief Commercial Officer, MRD, Adaptive Biotechnologies. Seattle, WA
$6.0M−$88K (−1.44%)
12736John W. Smither
Chief Financial Officer, Arcutis Biotherapeutics
$6.0M−$66K (−1.08%)
12737Valerie L. Jabbar
Senior Vice President, The Kroger. Cincinnati, OH
$6.0M−$98K (−1.61%)
12738Clifton E. Sifford
VICE CHAIR, INTERIM PRES & CEO, Shoe Station Group. Fort Mill, SC
$6.0M−$173K (−2.79%)
12739Livingston Satterthwaite
Director, IDEX. Fremont, CA
$6.0M−$215K (−3.45%)

Other Arcutis Biotherapeutics insiders

All ARQT insiders

Questions

How much stock does John W. Smither own?

John W. Smither holds $6,025,194 in listed stock based on SEC filings and current prices, mostly Arcutis Biotherapeutics (ARQT). That ranks 12736th on the Stock Rich List.

Is this John W. Smither's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did John W. Smither last buy or sell stock?

The most recent open-market trade on file is a sale of 1,600 NAMS shares on Sep 4, 2026 at $25.32.